45 computer-programmer-"University-of-Strasbourg" Fellowship positions at University of Birmingham
Sort by
Refine Your Search
-
to broader management/administration processes Contribute to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict
-
potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2028 Closing date: 15th July 2025 Background We are seeking an innovative Research Fellow in Computational
-
of activities within an established research programme and/or specific research project. Specifically, we are seeking a highly motivated Postdoctoral Researcher to join our team in the field of Natural
-
Birmingham Professional programme which provides all professional services staff with development opportunities and the encouragement to reach their full potential. With almost 5,000 professional services jobs
-
contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Our international group of highly motivated and
-
July 2025 Background To create and contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Role
-
at the University of Birmingham is pleased to offer a Part-Time Research Fellow post funded through the NIHR DEMCOMM Fellowship Programme. This post supports a motivated qualitative researcher to contribute
-
. Understanding of and ability to contribute to broader management/administration processes. Contribute to the planning and organising of the research programme and/or specific research project. Further particulars
-
to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict or duplication of effort Knowledge of the protected characteristics
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor